These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28635164)

  • 1. Assessing the toxicological significance of new psychoactive substances in fatalities.
    Elliott S; Sedefov R; Evans-Brown M
    Drug Test Anal; 2018 Jan; 10(1):120-126. PubMed ID: 28635164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4,4'-DMAR: chemistry, pharmacology and toxicology of a new synthetic stimulant of abuse.
    Coppola M; Mondola R
    Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):26-30. PubMed ID: 25819702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the risks associated with the use of new psychoactive substances (NPS): high variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products.
    Zamengo L; Frison G; Bettin C; Sciarrone R
    Toxicol Lett; 2014 Aug; 229(1):220-8. PubMed ID: 24910986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.
    Liakoni E; Dolder PC; Rentsch KM; Liechti ME
    BMC Pharmacol Toxicol; 2016 May; 17(1):25. PubMed ID: 27228985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New psychoactive substances: a public health issue.
    Guirguis A
    Int J Pharm Pract; 2017 Oct; 25(5):323-325. PubMed ID: 28895252
    [No Abstract]   [Full Text] [Related]  

  • 6. Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act.
    Webb NE; Wood DM; Greene SL; Hunter LJ; Archer JRH; Dines AM; Dargan PI
    Clin Toxicol (Phila); 2019 Jan; 57(1):36-41. PubMed ID: 30067112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN).
    Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Sedefov R; Dargan PI;
    Clin Toxicol (Phila); 2015 Nov; 53(9):893-900. PubMed ID: 26503789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
    Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDITORIAL New Psychoactive Substances (NPS), a New Global Issue: Neuropharmacological, Chemical and Toxicological Aspects.
    Pichini S; Busardo FP; Pacifici R; Kintz P
    Curr Neuropharmacol; 2017; 15(5):656-657. PubMed ID: 28000553
    [No Abstract]   [Full Text] [Related]  

  • 10. Making sense of differing overdose mortality: contributions to improved understanding of European patterns.
    Waal H; Gossop M
    Eur Addict Res; 2014; 20(1):8-15. PubMed ID: 23921286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
    Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
    Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An index of fatal toxicity for new psychoactive substances.
    King LA; Corkery JM
    J Psychopharmacol; 2018 Jul; 32(7):793-801. PubMed ID: 29482434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Psychoactive Substances and Trends of Abuse.
    Rivera JV; Vance EG; Rushton WF; Arnold JK
    Crit Care Nurs Q; 2017; 40(4):374-382. PubMed ID: 28834859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality related to novel psychoactive substances in Scotland, 2012: an exploratory study.
    McAuley A; Hecht G; Barnsdale L; Thomson CS; Graham L; Priyadarshi S; Robertson JR
    Int J Drug Policy; 2015 May; 26(5):461-7. PubMed ID: 25477285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel psychoactive substances: What educators need to know.
    Patterson ZR; Young MM; Vaccarino FJ
    Clin Pharmacol Ther; 2017 Feb; 101(2):173-175. PubMed ID: 27756105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe.
    Pirona A; Bo A; Hedrich D; Ferri M; van Gelder N; Giraudon I; Montanari L; Simon R; Mounteney J
    Int J Drug Policy; 2017 Feb; 40():84-92. PubMed ID: 27956184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recreational use, analysis and toxicity of tryptamines.
    Tittarelli R; Mannocchi G; Pantano F; Romolo FS
    Curr Neuropharmacol; 2015 Jan; 13(1):26-46. PubMed ID: 26074742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies.
    Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
    Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problems of accuracy in official statistics on drug-related deaths.
    Shai D
    Int J Addict; 1994 Dec; 29(14):1801-11. PubMed ID: 7890443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.